Home » Topics » BioWorld Science

BioWorld Science
RSS

CNRS, Universite d'Orleans identify novel agents for filovirus infections

April 12, 2018

Entasis Therapeutics patents new beta-lactamase inhibitors

April 12, 2018

Reata offers update on ongoing CARDINAL study of bardoxolone in Alport syndrome

April 12, 2018

Jiangsu Chia Tai Tianqing Pharmaceutical Group describes HBV capsid assembly inhibitors

April 12, 2018

Assembly Biosciences presents new hepatitis B core protein modulators

April 12, 2018

FDA lifts clinical hold on BPX-501 in U.S.

April 12, 2018

Novel LDLR-PCSK9 protein-protein interaction inhibitors discovered at Texas A&M University

April 12, 2018

Treos Bio activates U.S. site in phase I trial of PolyPEPI-1018

April 12, 2018

CNTO-3157 fails to attenuate rhinovirus-induced experimental asthma exacerbations

April 12, 2018

Veracyte enters collaboration with Loxo Oncology to advance oncology precision medicine

April 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...